In Depth 4 Feb 2025 World Cancer Day: trends in cancer therapeutics to look forward to in 2025 As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer care in 2025. February 4, 2025 - 14 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 12 Dec 2024 Top biotech deals of November 2024 November has seen a variety of biotech deals take place to advance therapies across different stages in development. December 12, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Reports Produced by Inpart 11 Dec 2024Antibody Therapy R&D trends and breakthrough innovations Check out a new report exploring R&D trends and breakthrough innovations leveraging antibodies to create potentially game-changing therapies, published by our parent company Inpart. December 11, 2024 Share WhatsApp Twitter Linkedin Email Produced by Inpart
Sponsored by Allucent 26 Nov 2024 Harnessing antibody-drug conjugates (ADCs) in oncology: Pathways to clinical success Discover how ADCs are advancing oncology, the regulatory challenges they face, and the promise they hold for the future of cancer treatment. November 26, 2024 - 8 minutesmins - By Will Chu Share WhatsApp Twitter Linkedin Email
Best in Biotech 14 Nov 2024 8 biotech companies advancing new treatments for breast cancer in 2024 Delve into the diverse landscape of breast cancer treatment with nine biotech companies currently developing new treatments. November 14, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 4 Nov 2024 Top biotech deals of October 2024 Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in October 2024. November 4, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Podcast 11 Oct 2024Bispecific ADCs: the next generation of cancer treatments To talk about bispecific ADCs, and biotechs in Czechia, our conversation this week is with Radek Špíšek, CEO of SOTIO. October 11, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Sponsored by KBI Biopharma 17 Sep 2024 ADCs that deliver: The secret lies in rigorous characterization Explore the challenges of ADC characterization, key techniques, and the benefits of partnering with a CDMO for effective development. September 17, 2024 - 7 minutesmins - By Ute Boronowsky Share WhatsApp Twitter Linkedin Email
News and Trends 4 Sep 2024 2024: a year of breakthroughs for endometrial cancer? New treatments have been approved by regulators for endometrial cancer, which are regarded as major therapeutic breakthroughs. September 4, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Podcast 21 Jun 2024How ADCs can deliver death cap mushroom toxins to treat cancer Listen to our conversation with Heidelberg Pharma about its lead amanitin-based ADC product candidate, HDP-101. June 21, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Best in Biotech 8 Feb 2024 Fourteen biotech companies spearheading the antibody drug conjugate industry The antibody-drug conjugate market has gained significant traction recently. Discover some of the top ADC companies in the industry. February 8, 2024 - 18 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 20 Nov 2023 M&As: what’s up with the ADC buying spree? Antibody drug conjugates (ADCs) have been much sought-after through investments of late, with big pharma eyeing these drugs developed by various biotechs, to eventually nab them. With yet another ADC being bought by Bristol Myers Squibb, and AbbVie’s proposed $10 billion deal to seize ImmunoGen’s oncology pipeline, are these drugs the golden ticket to targeted […] November 20, 2023 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email